Cronos Group Inc. (TSX:CRON)

Canada flag Canada · Delayed Price · Currency is CAD
3.460
-0.030 (-0.86%)
At close: Dec 5, 2025
20.98%
Market Cap 1.32B
Revenue (ttm) 184.36M
Net Income (ttm) 50.28M
Shares Out 382.89M
EPS (ttm) 0.13
PE Ratio 26.39
Forward PE 35.31
Dividend n/a
Ex-Dividend Date n/a
Volume 93,765
Average Volume 120,500
Open 3.430
Previous Close 3.490
Day's Range 3.430 - 3.485
52-Week Range 2.270 - 4.400
Beta 1.05
RSI 49.54
Earnings Date Feb 27, 2026

About Cronos Group

Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brand names. The company is based in Stayner, Canada. [Read more]

Sector Healthcare
Founded 2012
Employees 459
Stock Exchange Toronto Stock Exchange
Ticker Symbol CRON
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

Cronos Group (CRON) Enhances Lord Jones Line with New Cannabis Innovations

Cronos Group (CRON) Enhances Lord Jones Line with New Cannabis Innovations

11 days ago - GuruFocus

Investing in Cannabis: Three Leading Stocks to Watch This November

The U.S. cannabis market continues to evolve as new legislative discussions, consumer trends, and business developments shape the industry's momentum. Although volatility remains, investors are increa...

21 days ago - MarijuanaStocks

3 Of The Best Marijuana Stocks To Buy For Possible Gains In 2026

The big question for marijuana stock investors is how the market will react to the newly passed bill to reverse the 2018 Farm Bill. A new bill was recently passed with language that essentially overtu...

22 days ago - MarijuanaStocks

4 Cannabis Stocks Log Momentum Gains Even As Congress Re-Criminalizes Some THC Products In Spending Bill

Four cannabis stocks are demonstrating significant technical momentum, seemingly undeterred by new regulatory headwinds from Washington. Momentum Improves For 4 Cannabis Stocks The positive trend come...

22 days ago - Benzinga

4 Cannabis Stocks Log Momentum Gains Even As Congress Re-Criminalizes Some THC Products In Spending Bill

Four cannabis stocks are demonstrating significant technical momentum, seemingly undeterred by new regulatory headwinds from Washington.

22 days ago - Benzinga

Congressional hemp restrictions threaten $28 billion industry, sending companies scrambling

The congressional funding bill included a THC cap that effectively bans most hemp products, a move industry leaders say threatens the $28 billion market. More than 300,000 jobs are at risk, with econo...

22 days ago - CNBC

Cronos Group (CRON) Reports Record Q3 2025 Earnings

Cronos Group (CRON) Reports Record Q3 2025 Earnings

4 weeks ago - GuruFocus

Cronos Group Inc. (CRON:CA) Q3 2025 Earnings Call Transcript

Cronos Group Inc. (CRON:CA) Q3 2025 Earnings Call November 6, 2025 8:30 AM ESTCompany ParticipantsHarrison AaronMichael Gorenstein - President, CEO &...

4 weeks ago - Seeking Alpha

Cronos Group Inc (CRON) Q3 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ...

Cronos Group Inc (CRON) Q3 2025 Earnings Call Highlights: Record Revenue and Strategic Growth Amid Challenges

4 weeks ago - GuruFocus

Q3 2025 Cronos Group Inc Earnings Call Transcript

Q3 2025 Cronos Group Inc Earnings Call Transcript

4 weeks ago - GuruFocus

Cronos Group (CRON) Reports Record Q3 Revenue and Earnings

Cronos Group (CRON) Reports Record Q3 Revenue and Earnings

4 weeks ago - GuruFocus

Cronos Group Inc (CRON) Q3 2025 Earnings: Revenue Misses Estimates at $36.3 Million

Cronos Group Inc (CRON) Q3 2025 Earnings: Revenue Misses Estimates at $36.3 Million

4 weeks ago - GuruFocus

Cronos Group GAAP EPS of $0.07, revenue of $36.34M misses by $0.99M

Cronos Group reports Q3 GAAP EPS of $0.07 and $36.34M revenue, up 6.1% YoY but missing estimates.

4 weeks ago - Seeking Alpha

Top Canadian Cannabis Stocks to Watch in November 2025

The Canadian cannabis market continues to evolve as global demand expands and U.S. legalization remains a hot topic. Investors are watching closely as several major producers position themselves for r...

4 weeks ago - MarijuanaStocks

'Trump effect' raises hopes for cannabis rally as investors bet on federal reforms, softer marijuana stance

Cannabis stocks could rally on hopes for new hemp regulations and Trump's possible softer stance on marijuana, fueling investor optimism across the industry.

5 weeks ago - CNBC

Cannabis Investing 2025: 3 Pot Stocks to Watch Before November

The cannabis industry continues to evolve as investors prepare for potential U.S. federal reform and international market expansion. Despite short-term volatility, global demand for both medical and r...

5 weeks ago - MarijuanaStocks

Cronos (CRON) Reintroduces Popular Caramel Green Apple Edible for Fall

Cronos (CRON) Reintroduces Popular Caramel Green Apple Edible for Fall

5 weeks ago - GuruFocus

Cronos Group Inc. to Hold 2025 Third Quarter Earnings Conference Call on November 6, 2025

TORONTO, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2025 third quarter earnings conference call on Thursday, November 6, 2...

6 weeks ago - GlobeNewsWire

3 Canadian Cannabis Stocks to Watch as U.S. Legalization Gains Steam in 2025

The Canadian cannabis market continues to play a crucial role in the global marijuana industry. As U.S. legalization efforts gain traction, Canadian producers are positioning themselves for renewed gr...

7 weeks ago - MarijuanaStocks

Cronos Group (CRON) Launches New Multipack Format for Popular Gummies

Cronos Group (CRON) Launches New Multipack Format for Popular Gummies

2 months ago - GuruFocus

1 Major Reason Cannabis Stocks Surged This Week

Marijuana stocks are getting some attention this week following new interest from President Donald Trump.

2 months ago - The Motley Fool

Wall Street Breakfast Podcast: Weed Stocks Light Up

Cannabis stocks surged after Trump endorsed CBD for senior healthcare, citing its potential to revolutionize treatment and reduce healthcare costs. Shares of TLRY, CGC, CRON, and ACB soared double dig...

2 months ago - Seeking Alpha

Cronos Group Reaches Analyst Target Price

In recent trading, shares of Cronos Group Inc (Symbol: CRON) have crossed above the average analyst 12-month target price of $2.95, changing hands for $2.97/share. When a stock reaches the target an a...

2 months ago - Nasdaq

Cannabis stocks soar after Trump shares video promoting drug's use for seniors

Video posted on Truth Social touts CBD as a ‘gamechanger' and promotes Medicaid coverage of CBD products

2 months ago - The Guardian